| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8257ad60ee47fd2d2c2213f1a704dfe2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_00f7e84fde98b18619856ba7e698cfc9 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F1-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F1-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44 |
| filingDate |
2020-06-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4dc4a10c8ff3e75b704dded07fa64add
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ed181d89fed006435e1d3892e0515dbe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0c24f60329f0f2c402fbc854fa6f8019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4c32abdd393708f3a5263cb03bdfc4ce
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_216a9b5bcdb27436641b34d02d5a68f3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8b9c73a94ec62d5a877567e5dcdb9408 |
| publicationDate |
2022-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
BR-102020013240-A2 |
| titleOfInvention |
PHENOLIC BINUCLING BINDERS, BINUCLEAR METAL COMPOUNDS, VETERINARY MEDICAL COMPOSITION, BINUCLEAR BINDING SYNTHESIS PROCESSES, BINUCLEAR COMPOUNDS SYNTHESIS PROCESS, METHOD OF TREATMENT OF NEOPLASMS AND FUNGAL DISEASES AND USE |
| abstract |
The present invention deals with new metallodrugs containing a copper(II) binuclear coordination center and the non-symmetrical binucleating ligands 2-hydroxy-3-{[(2-hydroxybenzyl)(2-pyridylmethyl)amino]-methyl}-5 -methylbenzaldehyde isonicotinoyl hydrazone (H3L1) or 2-hydroxy-3-{bis[(2-pyridylmethyl)amino]-methyl}-5-methylbenzaldehyde isonicotinoyl hydrazone (H2L2) suitable for the treatment of neoplasms involving solid tumors and/or leukemias, as well as diseases of an opportunistic nature, such as diseases caused by pathogenic fungi. |
| priorityDate |
2020-06-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |